DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Prednisolone Sodium Phosphate is a drug marketed by Watson Labs, Akorn, Alcon Pharms Ltd, Bausch And Lomb, Sola Barnes Hind, Amneal Pharms, Chartwell Rx, Edenbridge Pharms, Medicis Pharms, Mission Pharma, Nesher Pharms, Pharm Assoc, Vintage, Vintage Pharms, We Pharms, Wockhardt Bio Ag, and Mylan Pharms Inc. and is included in twenty-nine NDAs.
The generic ingredient in PREDNISOLONE SODIUM PHOSPHATE is prednisolone sodium phosphate. There are eighty-eight drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
A generic version of PREDNISOLONE SODIUM PHOSPHATE was approved as prednisolone sodium phosphate by BAUSCH AND LOMB on July 29th, 1994.
Summary for PREDNISOLONE SODIUM PHOSPHATE
|Finished Product Suppliers / Packagers:||17|
|Raw Ingredient (Bulk) Api Vendors:||48|
|Formulation / Manufacturing:||see details|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for PREDNISOLONE SODIUM PHOSPHATE|
|What excipients (inactive ingredients) are in PREDNISOLONE SODIUM PHOSPHATE?||PREDNISOLONE SODIUM PHOSPHATE excipients list|
|DailyMed Link:||PREDNISOLONE SODIUM PHOSPHATE at DailyMed|
Recent Clinical Trials for PREDNISOLONE SODIUM PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
|Ocular Therapeutix||Phase 4|
|New England Retina Associates||Phase 4|
|Francis I. Proctor Foundation||Phase 2|